The results indicated that IGF2BP3 expression was positively correlated with infiltration of CD8+, CD4+ T cells, and B cells in each of the breast cancer subtypes (Additional file 5: Fig. S5a, b), which was similar to the effect of PD-L1 (CD274). Here, IGF2BP3 is linked to breast cancer.